#7862 on the rich list of 14,452 insiders
Bernard J. Zovighian
CEO at Edwards Lifesciences. Based in Irvine, California.
$11.6M
in disclosed stock, −$151K (−1.28%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 7862nd of 14,452
- Companies held
- 1
- Largest holding
- EW, 100.0% of total
- Latest SEC filing
- Nov 9, 2026
What the $11.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Edwards Lifesciences EW Common Stock | Directly | 98,845 | $103.88 | $10.3M | 88.7% | Form 4, Nov 9, 2026 |
| Edwards Lifesciences EW Common Stock | Through Trust | 8,916 | $103.88 | $926K | 8.0% | Form 4, Nov 9, 2026 |
| Edwards Lifesciences EW Common Stock | Indirectly (see filing footnote) | 3,734 | $103.88 | $388K | 3.3% | Form 4, Nov 9, 2026 |
Share counts are the amounts Bernard J. Zovighian reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Sold | EW | 9,184 | $103.39 | $949K | View |
| Nov 9, 2026 | Sold | EW | 13,916 | $102.78 | $1.4M | View |
| Jul 27, 2026 | Sold | EW | 2,921 | $83.93 | $245K | View |
| Jun 17, 2026 | Sold | EW | 523 | $87.92 | $46K | View |
| May 12, 2026 | Sold | EW | 35,506 | $77.92 | $2.8M | View |
| May 12, 2026 | Sold | EW | 845 | $78.40 | $66K | View |
| Feb 12, 2026 | Sold | EW | 19,898 | $76.61 | $1.5M | View |
| Feb 12, 2026 | Sold | EW | 2,532 | $77.13 | $195K | View |
| Dec 10, 2025 | Sold | EW | 3,863 | $83.45 | $322K | View |
| Dec 8, 2025 | Sold | EW | 21,487 | $85.21 | $1.8M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7859 | Todd S. Young SEE REMARKS, Elanco Animal Health. Franklin, TN | $11.6M |
| 7860 | Spencer Burton President and COO, The Ensign Group. San Juan Capistrano, CA | $11.6M |
| 7861 | Samarth Kulkarni Chief Executive Officer, CRISPR Therapeutics AG. Boston, MA | $11.6M |
| 7862 | Bernard J. Zovighian CEO, Edwards Lifesciences. Irvine, CA | $11.6M |
| 7863 | James Caci Chief Financial Officer, AvePoint. Jersey City, NJ | $11.6M |
| 7864 | Wendy A. Rummler Chief People Officer, Credit Acceptance. Southfield, MI | $11.6M |
| 7865 | Jacobo Ortiz Blanes Chief Operating Officer, Fermi. Amarillo, TX | $11.6M |
Other Edwards Lifesciences insiders
All EW insiders- Michael A. Mussallem$459MDirector. #511 overall
- Scott B. Ullem$32.5MCVP, Chief Financial Officer. #3357 overall
- Larry Wood$21.5MGlobal President TAVR & Surg. #3762 overall
- Jean-Luc M. Lemercier$19.2MCVP, EMEACLA and JAPAC. #5371 overall
- Donald E. Bobo Jr.$15.8MCVP,Strategy/Corp Development. #6163 overall
- Theodora Mistras$10.4MCVP, Chief Financial Officer. #7768 overall
Questions
How much stock does Bernard J. Zovighian own?
Bernard J. Zovighian holds $11,582,019 in listed stock based on SEC filings and current prices, mostly Edwards Lifesciences (EW). That ranks 7862nd on the Stock Rich List.
Is this Bernard J. Zovighian's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Bernard J. Zovighian last buy or sell stock?
The most recent open-market trade on file is a sale of 9,184 EW shares on Nov 9, 2026 at $103.39.